Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Mixed demand, currency headwind, and healthy cash flow (Cision) +++ ATLAS COPCO A Aktie -3,91%

ZIMMER BIOMET Aktie

 >ZIMMER BIOMET Aktienkurs 
81.84 EUR    +0.0%    (Tradegate)
Ask: 81.84 EUR / 74 Stück
Bid: 81.2 EUR / 74 Stück
Tagesumsatz: 50 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>ZIMMER BIOMET Performance
1 Woche: +0,3%
1 Monat: +2,6%
3 Monate: -5,2%
6 Monate: -22,7%
1 Jahr: -19,4%
laufendes Jahr: -19,7%
>ZIMMER BIOMET Aktie
Name:  ZIMMER BIOMET HLDGS DL-01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US98956P1021 / 753718
Symbol/ Ticker:  ZIM (Frankfurt) / ZBH (NYSE)
Kürzel:  FRA:ZIM, ETR:ZIM, ZIM:GR, NYSE:ZBH
Index:  S&P500
Webseite:  https://www.zimmerbiomet...
Marktkapitalisierung:  15570 Mio. EUR
Umsatz:  6677.04 Mio. EUR
EBITDA:  2211.23 Mio. EUR
Gewinn je Aktie:  3.365 EUR
Schulden:  6356.2 Mio. EUR
Liquide Mittel:  1196.66 Mio. EUR
Umsatz-/ Gewinnwachstum:  1.1% / 5.6%
KGV/ KGV lG:  20.71 / 11.72
KUV/ KBV/ PEG:  2.45 / 1.49 / 1.21
Gewinnm./ Eigenkapitalr.:  11.86% / 7.32%
Dividende je Aktie:  0.891 EUR
Dividendenrendite/ -schätzung:  1.1% / 1.06%
Div. Historie:  26.06.25 - 0.20591€
31.03.25 - 0.22169€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  ZIMMER BIOMET
Letzte Datenerhebung:  18.07.25
>Eigentümer
Aktien: 197.85 Mio. St.
f.h. Aktien: 197.25 Mio. St.
Insider Eigner: 0.15%
Instit. Eigner: 95.54%
 >Anleihen 
Es sind 3 Anleihen zur ZIMMER BIOMET Aktie bekannt.
>Peer Group

 
18.07.25 - 12:45
Weekly Recap: 12 Finance Press Releases You Need to See (PR Newswire)
 
A roundup of the most newsworthy financial press releases from PR Newswire this week, including Zimmer Biomet's acquisition of Monogram Technologies and S&P Global's collaboration with Anthropic. NEW YORK, July 18, 2025 /PRNewswire/ -- With thousands of press releases published each week,......
17.07.25 - 10:24
What You Need To Know Ahead of Zimmer Biomet€s Earnings Release (Barchart)
 
Zimmer Biomet is expected to announce its second-quarter results in the upcoming month, and analysts expect a low-single-digit drop in earnings....
14.07.25 - 17:24
Zimmer Biomet To Lead Orthopedic Robotics With Monogram€s AI Tech (Benzinga)
 
Zimmer Biomet plans to acquire Monogram and integrate its robotic knee system into its ROSA platform to support growth and product expansion through 2027. read more...
14.07.25 - 14:12
Zimmer Biomet To Acquire Monogram Technologies In All Cash Deal Valued At About $168 Mln (AFX)
 
WASHINGTON (dpa-AFX) - Medical technology company Zimmer Biomet Holdings, Inc. (ZBH), and Monogram Technologies Inc. (MGRM), an orthopedic robotics company, announced Monday they have entered into......
14.07.25 - 13:42
Zimmer Biomet to buy Monogram for $177M in cash (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.07.25 - 13:39
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions (GlobeNewswire EN)
 
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions...
14.07.25 - 06:24
Osteopore Granted Swiss Market Approval for Custom Bioresorbable Implants (Small Caps)
 
Regenerative medicine company Osteopore (ASX: OSX) has secured market approval in Switzerland for its off-the-shelf and custom-made biomimetic and bioresorbable implants. Approval came under the European Union's medical device regulations (MDR) and follows the company's partnership with US orthopaedic solutions company Zimmer Biomet to distribute its craniofacial products in Europe, the Middle East and Africa, the […] The post Osteopore Granted Swiss Market Approval for Custom Bioresorbable Implants appeared first on Small Caps....
10.07.25 - 15:01
Getinge and Zimmer Biomet announce strategic partnership in the ASC sector (Cision)
 
GOTHENBURG, SWEDEN AND WARSAW, IND. – July 10, 2025 – Global MedTech companies Getinge and Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), today announced a strategic partnership where Zimmer Biomet will distribute Getinge's Operating Room (OR) capital products to its Ambulatory Surgery Center (ASC) customers. This partnership creates a turnkey solution for ASC customers, who can now access Getinge's infection control and surgical portfolio and Zimmer Biomet's broad menu of best-in-class implants and surgical robotics from a single source. [image] ASCs are modern healthcare facilities...
09.07.25 - 13:33
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results (PR Newswire)
 
WARSAW, Ind., July 9, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will be webcast on Thursday, August 7, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that......
26.06.25 - 00:01
XFRA: DIVIDEND/INTEREST INFORMATION - 26.06.2025 - EQUBF_01 (XETRA)
 
Das Instrument ZIM US98956P1021 ZIMMER BIOMET HLDGS DL-01 EQUITY wird ex Dividende/Zinsen gehandelt am 26.06.2025 The instrument ZIM US98956P1021 ZIMMER BIOMET HLDGS DL-01 EQUITY has its ex-dividend/interest day on 26.06.2025...
17.06.25 - 14:42
Is Zimmer Biomet Stock Underperforming the Nasdaq? (Barchart)
 
Zimmer Biomet has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock's prospects....
05.06.25 - 19:27
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.06.25 - 19:03
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology (GlobeNewswire EN)
 
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, “Zimmer”) (NYSE: ZBH), alleging infringement of 4 patents related to Treace's innovative Lapiplasty® 3D Bunion Correction® technologies. The suit was filed in the United States District Court for the District of Delaware, and seeks injunctive relief and damages....
30.05.25 - 14:24
Zimmer Biomet declares $0.24 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.05.25 - 13:01
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 (PR Newswire)
 
WARSAW, Ind., May 30, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2025. The cash......
29.05.25 - 16:18
Zimmer Biomet Chairman, President and CEO Ivan Tornos Joins OREF Board of Trustees (PR Newswire)
 
ROSEMONT, Ill., May 29, 2025 /PRNewswire/ -- The Orthopaedic Research and Education Foundation (OREF), the leading private nonprofit organization funding musculoskeletal (MSK) research across all orthopaedic sub-specialties, is pleased to announce that Ivan Tornos, Chairman, President and......
27.05.25 - 13:30
Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas (PR Newswire)
 
WARSAW, Ind., May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kevin Thornal as Group President, Global Businesses and the Americas. Reporting to Chairman-Elect, President and CEO Ivan......
22.05.25 - 13:30
Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (PR Newswire)
 
WARSAW, Ind., May 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025, at 9:20 a.m. ET. A live......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der König der Flöhe ist in Tiberias. - D. h., das Schlechte mag eine ganz andere Ursache haben als man vermutet. - Sprichwort Arabisch
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!